1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing screening for hormonal deficiency
5.1.1.2. Rising awareness and growing income of women
5.1.1.3. Prevalence of hormonal deficiency in the populace
5.1.1.4. Rise in geriatric population
5.1.2. Restraints
5.1.2.1. Strict regulations and complicated approval process
5.1.2.2. Varying side effects such as blurred vision or risk of breast cancer and heart attack
5.1.3. Opportunities
5.1.3.1. Concentration of major research companies in the developed countries
5.1.3.2. Formulation of customized hormonal therapy for specific patients
5.1.4. Challenges
5.1.4.1. Lack of quality control on purity and safety of the product compared to synthetic hormone products
5.2. Cumulative Impact of COVID-19

6. Bioidentical Hormones Market, by Hormones Type
6.1. Introduction
6.2. Estrogens
6.3. Progesterone
6.4. Testosterone

7. Bioidentical Hormones Market, by Product
7.1. Introduction
7.2. Creams and Gels
7.3. Injectable
7.4. Patches and Implants
7.5. Tablets and Capsules

8. Bioidentical Hormones Market, by End User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Hospitals & Clinics

9. Americas Bioidentical Hormones Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Bioidentical Hormones Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Bioidentical Hormones Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Allergan Inc
13.2. Bayers AG
13.3. BIOSTATION
13.4. BioTE Medical
13.5. Bravado Labs
13.6. Defy Medical LLC
13.7. Full Life Wellness Center
13.8. GeneScience Pharmaceuticals Co. LTD
13.9. InMode Ltd.
13.10. MERCK KGAA
13.11. NextGenRx Compounding Pharmacy
13.12. Novartis AG
13.13. Noven Therapeutics, LLC.
13.14. Novo Nordisk A/S
13.15. Nueva Aesthetics
13.16. Opt Health
13.17. Orion Pharma AB
13.18. Pavilion Compounding Pharmacy, LLC
13.19. Pellecome LLC
13.20. PFIZER INC
13.21. Schwietermans Pharmacy
13.22. SottoPelle
13.23. SUPREMA HQ
13.24. TherapeuticsMD Inc.
13.25. United Pharmacy, LLC.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL BIOIDENTICAL HORMONES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL BIOIDENTICAL HORMONES MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2020 VS 2027 (%)
FIGURE 4. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2027
FIGURE 6. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY ESTROGENS, 2018-2027 (USD MILLION)
FIGURE 7. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY ESTROGENS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 8. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PROGESTERONE, 2018-2027 (USD MILLION)
FIGURE 9. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PROGESTERONE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 10. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TESTOSTERONE, 2018-2027 (USD MILLION)
FIGURE 11. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TESTOSTERONE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 12. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2020 VS 2027 (%)
FIGURE 13. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2020 VS 2027 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2027
FIGURE 15. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY CREAMS AND GELS, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY CREAMS AND GELS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PATCHES AND IMPLANTS, 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PATCHES AND IMPLANTS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TABLETS AND CAPSULES, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TABLETS AND CAPSULES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2020 VS 2027 (%)
FIGURE 24. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2020 VS 2027 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2027
FIGURE 26. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2027 (USD MILLION)
FIGURE 29. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 30. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 31. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 32. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 33. CANADA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. AUSTRALIA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. CHINA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. INDIA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. INDONESIA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. JAPAN BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. MALAYSIA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. PHILIPPINES BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. SINGAPORE BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. SOUTH KOREA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. TAIWAN BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. THAILAND BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. ITALY BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. NETHERLANDS BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. QATAR BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. GLOBAL BIOIDENTICAL HORMONES MARKET: FPNV POSITIONING MATRIX
FIGURE 61. GLOBAL BIOIDENTICAL HORMONES MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 62. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOIDENTICAL HORMONES MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL BIOIDENTICAL HORMONES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY ESTROGENS, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PROGESTERONE, BY REGION, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TESTOSTERONE, BY REGION, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY CREAMS AND GELS, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PATCHES AND IMPLANTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TABLETS AND CAPSULES, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 16. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 17. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 18. CANADA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 19. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 21. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 22. AUSTRALIA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 23. CHINA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 24. INDIA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 25. INDONESIA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 26. JAPAN BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 27. MALAYSIA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 28. PHILIPPINES BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 29. SINGAPORE BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 30. SOUTH KOREA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 31. TAIWAN BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 32. THAILAND BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 36. ITALY BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. NETHERLANDS BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 38. QATAR BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 42. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 44. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 45. GLOBAL BIOIDENTICAL HORMONES MARKET: SCORES
TABLE 46. GLOBAL BIOIDENTICAL HORMONES MARKET: BUSINESS STRATEGY
TABLE 47. GLOBAL BIOIDENTICAL HORMONES MARKET: PRODUCT SATISFACTION
TABLE 48. GLOBAL BIOIDENTICAL HORMONES MARKET: RANKING
TABLE 49. GLOBAL BIOIDENTICAL HORMONES MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 50. GLOBAL BIOIDENTICAL HORMONES MARKET: MERGER & ACQUISITION
TABLE 51. GLOBAL BIOIDENTICAL HORMONES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 52. GLOBAL BIOIDENTICAL HORMONES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 53. GLOBAL BIOIDENTICAL HORMONES MARKET: INVESTMENT & FUNDING
TABLE 54. GLOBAL BIOIDENTICAL HORMONES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 55. GLOBAL BIOIDENTICAL HORMONES MARKET: LICENSE & PRICING

Companies Mentioned

Allergan Inc
Bayers AG
BIOSTATION
BioTE Medical
Bravado Labs
Defy Medical LLC
Full Life Wellness Center
GeneScience Pharmaceuticals Co. LTD
InMode Ltd.
MERCK KGAA
NextGenRx Compounding Pharmacy
Novartis AG
Noven Therapeutics, LLC.
Novo Nordisk A/S
Nueva Aesthetics
Opt Health
Orion Pharma AB
Pavilion Compounding Pharmacy, LLC
Pellecome LLC
PFIZER INC
Schwietermans Pharmacy
SottoPelle
SUPREMA HQ
TherapeuticsMD Inc.
United Pharmacy, LLC.